Contraceptive challenges and the transgender individual.

Women's midlife health Pub Date : 2018-07-13 eCollection Date: 2018-01-01 DOI:10.1186/s40695-018-0042-1
A Francis, S Jasani, G Bachmann
{"title":"Contraceptive challenges and the transgender individual.","authors":"A Francis,&nbsp;S Jasani,&nbsp;G Bachmann","doi":"10.1186/s40695-018-0042-1","DOIUrl":null,"url":null,"abstract":"<p><p>In recent years public awareness of healthcare disparities experienced by transgender individuals throughout the world have garnered increasing attention within the media and from health advocates. Despite this increasing awareness, a paucity of research data and clinical protocols of care for clinicians continues to exist, especially in regard to the transgender individual's family planning needs. Clinicians should be on the forefront of promoting strategies that forge a meaningful and collaborative relationship with the transgender man, including as he transitions through to the menopause and his sexual and reproductive healthcare needs. Unfortunately, despite best efforts to address the health concerns of transgender men in midlife, including their contraceptive needs and pregnancy desires, there is currently a paucity of research. Although hormonal contraceptives are not an option for this group of individuals, especially those on masculinizing hormones, IUD's, both copper containing and progestin containing, should be considered for those with intact pelvic organs. For this group of transgender men with potential for pregnancy who have either completed their family or choose not to give birth, sterilization can be offered. Regardless of where they identify along the gender spectrum, these midlife individuals with potential reproductive potential should have equitable access to and up to date counseling on their contraceptive options. This commentary addresses the contraceptive challenges of the midlife transgender man. (Note: Pronouns used in this article are he/him for cis and transgender men and she/her for cis and transgender women).</p>","PeriodicalId":75330,"journal":{"name":"Women's midlife health","volume":" ","pages":"12"},"PeriodicalIF":0.0000,"publicationDate":"2018-07-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s40695-018-0042-1","citationCount":"18","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Women's midlife health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s40695-018-0042-1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2018/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 18

Abstract

In recent years public awareness of healthcare disparities experienced by transgender individuals throughout the world have garnered increasing attention within the media and from health advocates. Despite this increasing awareness, a paucity of research data and clinical protocols of care for clinicians continues to exist, especially in regard to the transgender individual's family planning needs. Clinicians should be on the forefront of promoting strategies that forge a meaningful and collaborative relationship with the transgender man, including as he transitions through to the menopause and his sexual and reproductive healthcare needs. Unfortunately, despite best efforts to address the health concerns of transgender men in midlife, including their contraceptive needs and pregnancy desires, there is currently a paucity of research. Although hormonal contraceptives are not an option for this group of individuals, especially those on masculinizing hormones, IUD's, both copper containing and progestin containing, should be considered for those with intact pelvic organs. For this group of transgender men with potential for pregnancy who have either completed their family or choose not to give birth, sterilization can be offered. Regardless of where they identify along the gender spectrum, these midlife individuals with potential reproductive potential should have equitable access to and up to date counseling on their contraceptive options. This commentary addresses the contraceptive challenges of the midlife transgender man. (Note: Pronouns used in this article are he/him for cis and transgender men and she/her for cis and transgender women).

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
避孕挑战和跨性别个体。
近年来,公众对世界各地跨性别者所经历的医疗保健差异的认识,在媒体和健康倡导者中引起了越来越多的关注。尽管人们对这一问题的认识不断提高,但临床医生仍然缺乏研究数据和临床护理方案,特别是在跨性别者的计划生育需求方面。临床医生应该站在促进与跨性别男性建立有意义的合作关系的战略的前沿,包括他过渡到更年期以及他的性和生殖保健需求。不幸的是,尽管尽了最大努力解决中年变性男子的健康问题,包括他们的避孕需求和怀孕愿望,但目前缺乏研究。虽然激素避孕药不适合这类人,尤其是那些使用男性化激素的人,但对于那些盆腔器官完好的人来说,应该考虑使用含铜和含黄体酮的宫内节育器。对于这群有可能怀孕的跨性别男性,他们要么完成了家庭,要么选择不生育,可以提供绝育手术。无论他们的性别定位如何,这些具有潜在生殖潜力的中年个体都应该公平地获得有关避孕选择的最新咨询。这篇评论论述了中年变性人在避孕方面的挑战。(注:本文中对顺性和变性男性使用代词he/him,对顺性和变性女性使用代词she/her)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
审稿时长
7 weeks
期刊最新文献
Correction to: Factors predicting age at menopause among Iranian women in the Bandare-Kong cohort study (a cross-sectional survey of PERSIAN cohort study). Women's midlife health: the unfinished research agenda. Stressful life events during the perimenopause: longitudinal observations from the seattle midlife women's health study. Factors predicting age at menopause among Iranian women in the Bandare-Kong cohort study (a cross-sectional survey of PERSIAN cohort study). Factors associated with the CVD risk factors and body fat pattern of postmenopausal Hindu caste and Lodha tribal populations living in India: An exploratory study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1